Cargando…

The clinicopathological features and prognosis of signet ring cell carcinoma of the esophagus: A 10-year retrospective study in China

OBJECTIVES: The aim of this study was to analyze the clinicopathological features and prognosis of esophageal signet ring cell (SRC) carcinoma in China. METHODS: Patients with poorly differentiated adenocarcinoma were identified in two hospitals from January 2006 to June 2016. The patients were divi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lei, Liu, Xi, Gao, Linggen, Wang, Rong, Gao, Dewei, Bai, Dongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423587/
https://www.ncbi.nlm.nih.gov/pubmed/28486494
http://dx.doi.org/10.1371/journal.pone.0176637
_version_ 1783234974230511616
author Chen, Lei
Liu, Xi
Gao, Linggen
Wang, Rong
Gao, Dewei
Bai, Dongyu
author_facet Chen, Lei
Liu, Xi
Gao, Linggen
Wang, Rong
Gao, Dewei
Bai, Dongyu
author_sort Chen, Lei
collection PubMed
description OBJECTIVES: The aim of this study was to analyze the clinicopathological features and prognosis of esophageal signet ring cell (SRC) carcinoma in China. METHODS: Patients with poorly differentiated adenocarcinoma were identified in two hospitals from January 2006 to June 2016. The patients were divided into three groups according to component of SRCs: SRC≥50% group, SRC < 50% group and non-SRC poorly differentiated adenocarcinoma group. RESULTS: Fifty-seven patients had carcinoma (SRC≥50%), and 79 patients had tumors containing <50% SRCs, and 535 patients was in non-SRC poorly differentiated adenocarcinoma group. There were no significant differences among the three groups in clinicopathological characteristics. Patients in SRC≥50% group had a lower overall survival rate (at 3-year 37.6%versus71.1%; at 5-year 0% versus 43.3%; p<0.001) compared with the control group. Even survival outcome of patients in SRC < 50%was inferior to that of in control group (at 3-year 53.0%versus71.1%; at 5-year 25.9% versus 43.3%; p<0.001). Female sex, large tumor size and increasing TNM stage were independent prognostic factors for SRC ≥50% esophageal carcinoma patients. CONCLUSIONS: The incidence of esophageal SRC carcinoma is relatively rare and the worst outcome is observed in the SRC≥ 50% group. It is necessary to explore new therapeutic modalities to achieve further improvements in the clinical outcome of these patients.
format Online
Article
Text
id pubmed-5423587
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-54235872017-05-15 The clinicopathological features and prognosis of signet ring cell carcinoma of the esophagus: A 10-year retrospective study in China Chen, Lei Liu, Xi Gao, Linggen Wang, Rong Gao, Dewei Bai, Dongyu PLoS One Research Article OBJECTIVES: The aim of this study was to analyze the clinicopathological features and prognosis of esophageal signet ring cell (SRC) carcinoma in China. METHODS: Patients with poorly differentiated adenocarcinoma were identified in two hospitals from January 2006 to June 2016. The patients were divided into three groups according to component of SRCs: SRC≥50% group, SRC < 50% group and non-SRC poorly differentiated adenocarcinoma group. RESULTS: Fifty-seven patients had carcinoma (SRC≥50%), and 79 patients had tumors containing <50% SRCs, and 535 patients was in non-SRC poorly differentiated adenocarcinoma group. There were no significant differences among the three groups in clinicopathological characteristics. Patients in SRC≥50% group had a lower overall survival rate (at 3-year 37.6%versus71.1%; at 5-year 0% versus 43.3%; p<0.001) compared with the control group. Even survival outcome of patients in SRC < 50%was inferior to that of in control group (at 3-year 53.0%versus71.1%; at 5-year 25.9% versus 43.3%; p<0.001). Female sex, large tumor size and increasing TNM stage were independent prognostic factors for SRC ≥50% esophageal carcinoma patients. CONCLUSIONS: The incidence of esophageal SRC carcinoma is relatively rare and the worst outcome is observed in the SRC≥ 50% group. It is necessary to explore new therapeutic modalities to achieve further improvements in the clinical outcome of these patients. Public Library of Science 2017-05-09 /pmc/articles/PMC5423587/ /pubmed/28486494 http://dx.doi.org/10.1371/journal.pone.0176637 Text en © 2017 Chen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Chen, Lei
Liu, Xi
Gao, Linggen
Wang, Rong
Gao, Dewei
Bai, Dongyu
The clinicopathological features and prognosis of signet ring cell carcinoma of the esophagus: A 10-year retrospective study in China
title The clinicopathological features and prognosis of signet ring cell carcinoma of the esophagus: A 10-year retrospective study in China
title_full The clinicopathological features and prognosis of signet ring cell carcinoma of the esophagus: A 10-year retrospective study in China
title_fullStr The clinicopathological features and prognosis of signet ring cell carcinoma of the esophagus: A 10-year retrospective study in China
title_full_unstemmed The clinicopathological features and prognosis of signet ring cell carcinoma of the esophagus: A 10-year retrospective study in China
title_short The clinicopathological features and prognosis of signet ring cell carcinoma of the esophagus: A 10-year retrospective study in China
title_sort clinicopathological features and prognosis of signet ring cell carcinoma of the esophagus: a 10-year retrospective study in china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423587/
https://www.ncbi.nlm.nih.gov/pubmed/28486494
http://dx.doi.org/10.1371/journal.pone.0176637
work_keys_str_mv AT chenlei theclinicopathologicalfeaturesandprognosisofsignetringcellcarcinomaoftheesophagusa10yearretrospectivestudyinchina
AT liuxi theclinicopathologicalfeaturesandprognosisofsignetringcellcarcinomaoftheesophagusa10yearretrospectivestudyinchina
AT gaolinggen theclinicopathologicalfeaturesandprognosisofsignetringcellcarcinomaoftheesophagusa10yearretrospectivestudyinchina
AT wangrong theclinicopathologicalfeaturesandprognosisofsignetringcellcarcinomaoftheesophagusa10yearretrospectivestudyinchina
AT gaodewei theclinicopathologicalfeaturesandprognosisofsignetringcellcarcinomaoftheesophagusa10yearretrospectivestudyinchina
AT baidongyu theclinicopathologicalfeaturesandprognosisofsignetringcellcarcinomaoftheesophagusa10yearretrospectivestudyinchina
AT chenlei clinicopathologicalfeaturesandprognosisofsignetringcellcarcinomaoftheesophagusa10yearretrospectivestudyinchina
AT liuxi clinicopathologicalfeaturesandprognosisofsignetringcellcarcinomaoftheesophagusa10yearretrospectivestudyinchina
AT gaolinggen clinicopathologicalfeaturesandprognosisofsignetringcellcarcinomaoftheesophagusa10yearretrospectivestudyinchina
AT wangrong clinicopathologicalfeaturesandprognosisofsignetringcellcarcinomaoftheesophagusa10yearretrospectivestudyinchina
AT gaodewei clinicopathologicalfeaturesandprognosisofsignetringcellcarcinomaoftheesophagusa10yearretrospectivestudyinchina
AT baidongyu clinicopathologicalfeaturesandprognosisofsignetringcellcarcinomaoftheesophagusa10yearretrospectivestudyinchina